Charles Forsyth

Charles Forsyth has extensive experience in financial planning and analysis. Charles started their career as a Financial Analyst at Iron Mountain in 2007. From 2010 to 2014, they worked as a Senior Financial Analyst at Philips Healthcare. Charles then joined Foundation Medicine, where they held various roles, including Manager and Senior Manager of Financial Planning and Analysis from 2014 to 2018. After that, they worked at Dicerna Pharmaceuticals, Inc. as an Associate Director and later as a Director of R&D Financial and Strategic Planning from 2018 to 2021. Charles then joined EQRx as the Director of Financial Planning and Analysis from 2021 to 2022. Charles subsequently held the same position at Selecta Biosciences from 2022 to 2023. Currently, they hold the position of Senior Director of Financial Planning and Analysis at Cartesian Therapeutics since November 2023.

Charles Forsyth has a Master of Business Administration (M.B.A.) degree from Boston College. Charles also has a Bachelor of Arts (BA) degree in Economics/Finance from the University of Massachusetts Amherst.